Adage Capital Partners Gp, L.L.C. Akouos, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$11.87 - $15.96 $2.64 Million - $3.55 Million	-222,418 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.87 - $21.04 $2.53 Million - $3.84 Million	-182,582 Reduced 45.08%	222,418 $3.09 Million
Q4 2020 Feb 16, 2021	SELL	$17.03 - $22.45 $1.09 Million - $1.44 Million	-64,000 Reduced 13.65%	405,000 $8.03 Million
Q3 2020 Nov 16, 2020	SELL	$19.3 - $26.92 $1.37 Million - $1.91 Million	-71,000 Reduced 13.15%	469,000 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$22.0 - $22.5 $11.9 Million - $12.2 Million	540,000 New	540,000 $12.2 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.